Skip to content

Combined immunomodulating properties of 3,4‐methylenedioxymethamphetamine (MDMA) and cannabis in humans

Roberta Pacifici, Piergiorgio Zuccaro, Magı́ Farré, Sandra Poudevida, Sergio Abanades, Simona Pichini, Klaus Langohr, Jordi Segura, Rafael de la Torre

Addiction May 22, 2007 DOI: 10.1111/j.1360-0443.2007.01805.x (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Longitudinal prospective study Peer reviewed
Sample size 94
Population Polydrug consumers of MDMA and cannabis, cannabis-only users, and non-users
Duration 1 year follow-up
Topics Cannabis MDMA
Keywords Immune system Interleukin Immunology
Citations 39
Key findings Long-term alterations in immunological homeostasis, including decreased IL-2 and increased TGF-β1, were observed in MDMA–cannabis users and were associated with a higher rate of mild infections.

Abstract

ABSTRACT Aims Cell‐mediated immune function and the occurrence of mild infectious diseases was investigated.

Participants: Polydrug consumers of 3,4‐methylenedioxymethamphetamine (MDMA) and cannabis ( n = 37) compared to cannabis users only ( n = 23) and control group ( n = 34).

Design: A longitudinal prospective study with three cross‐sectional evaluations at time 0 and at 6 months and 1 year was performed.

Findings: At baseline, a significant decrease in interleukin (IL)‐2 and an increase in anti‐inflammatory transforming growth factor (TGF)‐β1, together with a decrease in the number of total lymphocytes, CD4 and natural killer (NK) cells were observed in the MDMA–cannabis group, with intermediate alterations in the cannabis group. Immune alterations observed at baseline were sustained over time. No differences were found between regular and occasional MDMA users. A significantly higher rate of mild infections in regular MDMA–cannabis users compared with occasional MDMA–cannabis users and the remaining groups was observed.

Conclusions: The present data confirm that long‐term alterations in immunological homeostasis may result in general health status impairment and subsequent increased susceptibility to infection and immune‐related disorders.

Explore topics